Baruch Kuppermann

Baruch Kuppermann

University of California, Irvine

H-index: 59

North America-United States

About Baruch Kuppermann

Baruch Kuppermann, With an exceptional h-index of 59 and a recent h-index of 33 (since 2020), a distinguished researcher at University of California, Irvine, specializes in the field of retina, ophthalmology, pharmacology, clinical trials.

His recent articles reflect a diverse array of research interests and contributions to the field:

Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by …

Aflibercept biosimilars–update on the development progress

Results: Compared to severely ill COVID-19 patients and patients with fatal COVID-19 outcomes, the asymptomatic COVID-19 patients displayed

High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from …

Biosimilar ranibizumab in India-overview of phase 3 clinical trial designs

A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and …

Biosimilar anti-VEGF-is prefilled syringe (PFS) a challenge?

Port delivery system with ranibizumab (Susvimo) recall-What does it mean to the retina specialists

Baruch Kuppermann Information

University

Position

Professor of Ophthalmology

Citations(all)

14364

Citations(since 2020)

4210

Cited By

11612

hIndex(all)

59

hIndex(since 2020)

33

i10Index(all)

176

i10Index(since 2020)

111

Email

University Profile Page

University of California, Irvine

Google Scholar

View Google Scholar Profile

Baruch Kuppermann Skills & Research Interests

retina

ophthalmology

pharmacology

clinical trials

Top articles of Baruch Kuppermann

Title

Journal

Author(s)

Publication Date

Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by …

bioRxiv

Swayam Prakash

Nisha R Dhanushkodi

Latifa Zayou

Izabela Coimbra Ibraim

Afshana Quadiri

...

2023/5/24

Aflibercept biosimilars–update on the development progress

Eye

Ashish Sharma

Anat Loewenstein

Nilesh Kumar

Nikulaa Parachuri

Francesco Bandello

...

2024/4

Results: Compared to severely ill COVID-19 patients and patients with fatal COVID-19 outcomes, the asymptomatic COVID-19 patients displayed

Pedro A Reche

Sarah Elizabeth Jackson

Ricardo Da Silva Antunes

Lbachir BenMohamed

PG Coulon

...

2024

High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from …

Frontiers in Immunology

Pierre-Gregoire Coulon

Swayam Prakash

Nisha R Dhanushkodi

Ruchi Srivastava

Latifa Zayou

...

2024/3/28

Biosimilar ranibizumab in India-overview of phase 3 clinical trial designs

Ashish Sharma

Nilesh Kumar

Nikulaa Parachuri

Francesco Bandello

Anat Loewenstein

...

2024/3/4

A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and …

bioRxiv

Swayam Prakash

Nisha R Dhanushkodi

Mahmoud Singer

Afshana Quadiri

Latifa Zayou

...

2024/2/15

Biosimilar anti-VEGF-is prefilled syringe (PFS) a challenge?

Eye

Ashish Sharma

Anat Loewenstein

Nikulaa Parachuri

Nilesh Kumar

Alok Rasal

...

2024/2

Port delivery system with ranibizumab (Susvimo) recall-What does it mean to the retina specialists

International journal of retina and vitreous

Ashish Sharma

Arshad M Khanani

Nikulaa Parachuri

Nilesh Kumar

Francesco Bandello

...

2023/1/30

Determination of Humanin Fragments in Human Blood Plasma Samples

Investigative Ophthalmology & Visual Science

Farid Jose Thomaz Neto

Mustafa Ozgul

Astghik Ghazaryan

MARISABEL ANDRADE MELENDEZ

Baruch D Kuppermann

...

2023/6/1

Real-world practice patterns of eplerenone use for central serous chorioretinopathy

International Journal of Retina and Vitreous

Ramesh Venkatesh

Vishma Prabhu

Aishwarya Joshi

Rubble Mangla

Rishi Singh

...

2023/10/2

Biosimilar ranibizumab interchangeability: what does it mean to retinal physicians?

Eye

Ashish Sharma

Nilesh Kumar

Nikulaa Parachuri

Carl Regillo

Francesco Bandello

...

2023/7

Rodrigo Donato Costa1, 2, Farid José Thomaz Neto1, M. Tarek Moustafa1, 3, Shari R. Atilano1, Marilyn Chwa1

Javier Cáceres‑del‑Carpi

Mohamed Hamid Mohamed

M Cristina Kenney

Baruch D Kuppermann

2023

Stability determination of intact humanin-G with characterizations of oxidation and dimerization patterns

Biomolecules

Mustafa Ozgul

Anthony B Nesburn

Nader Nasralla

Benjamin Katz

Enes Taylan

...

2023/3/11

Potential Therapeutic Functions of PU-91 and Quercetin in Personalized Cybrids Derived from Patients with Age-Related Macular Degeneration, Keratoconus, and Glaucoma

Antioxidants

Nasim Salimiaghdam

Lata Singh

Mithalesh Kumar Singh

Marilyn Chwa

Shari Atilano

...

2023/6/22

Preparing for the next decade of anti-VEGF biosimilars for retinal diseases: a focus on South Asia

Ashish Sharma

Nilesh Kumar

Nikulaa Parachuri

Anat Loewenstein

Francesco Bandello

...

2023/8/3

Vitreal Concentrations of Vascular Endothelial Growth Factor in Patients with Rhegmatogenous Retinal Detachment

Journal of clinical medicine

Hossein Hasanpour

Maria Cristina Kenney

Baruch D Kuppermann

Mohammad Riazi Esfahani

Mozhgan Rezaei Kanavi

...

2023/2/5

Biosimilar anti-VEGF—Yardsticks to ensure biosimilarity

Eye

Ashish Sharma

Nikulaa Parachuri

Nilesh Kumar

Francesco Bandello

Baruch D Kuppermann

2023/1

Effects of Mitochondria on Ferroptotic pathway in Human Retinal Cells

Investigative Ophthalmology & Visual Science

MARISABEL ANDRADE MELENDEZ

Kevin Schneider

Mithalesh Kumar Singh

Farid Jose Thomaz Neto

Astghik Ghazaryan

...

2023/6/1

Biosimilar to biosimilar anti-VEGF switching for retinal diseases

Journal of VitreoRetinal Diseases

Ashish Sharma

Anat Loewenstein

Nikulaa Parachuri

Nilesh Kumar

Baruch D Kuppermann

2023/11

Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER–survey)

Ashish Sharma

Frank G Holz

Carl D Regillo

K Bailey Freund

David Sarraf

...

2023/8/3

See List of Professors in Baruch Kuppermann University(University of California, Irvine)